Rosie Scuccimarri, MD
Kawasaki Disease • Juvenile Arthritis • Rheumatic Diseases
My research focuses on the outcomes of Kawasaki Disease and Juvenile Idiopathic Arthritis (JIA). I am involved in 2 panCanadian research groups - ReACCh-Out (studies the outcomes of JIA) and the STOPP Consortium (studies the bone health of children with chronic diseases on corticosteroids). I am also presently studying the prevalence of Pediatric Rheumatic Diseases in East Africa.
Guzman J, Oen K, Tucker LB, Huber AM, Shiff N, Boire G, Scuccimarri R, et al for the ReACCh-Out investigators. The Outcomes of Juvenile Idiopathic Arthritis in Children Managed with Contemporary Treatments: Results from the ReACCh-Out cohort. Annals Rheum Dis. 2014 May 19. [Epub ahead of print]
McNeal-Davidson A, Fournier A, Scuccimarri R, Dancea A, Houde C, Bellavance M, Dahdah N. The fate and observed management of giant coronary artery aneurysms secondary to Kawasaki disease in the province of Quebec: The complete series since 1976. Pediatr Cardiol. 2013;34:170-8.
Berard R, Whittemore B, Scuccimarri R. Hemolytic Anemia following Intravenous Immunoglobulin therapy in patients treated for Kawasaki Disease: A Report of 4 Cases. Pediatr Rheumatol Online J. 2012 Apr 16;10(1):10.
Scuccimarri R. Kawasaki Disease. Pediatr Clin North Am. 2012 Apr;59(2):425-45.
Rodd C, Lang B, Ramsay T, Alos N, Huber AM, Cabral DA, Scuccimarri R, et al. Canadian Steroid-Associated Osteoporosis in the Pediatric Population (STOPP) Consortium. Incident vertebral fractures among children with rheumatic disorders 12 months after glucocorticoid initiation: a national observational study. Arthritis Care Res (Hoboken). 2012 Jan;64(1):122-31.